humans |
50 |
animals |
49 |
coronavirus |
38 |
influenza |
38 |
molecular sequence data |
37 |
sars-cov-2 |
37 |
phylogeny |
31 |
hong kong - epidemiology |
27 |
covid-19 |
24 |
genome, viral |
22 |
china |
21 |
reverse transcriptase polymerase chain reaction |
20 |
hong kong |
19 |
influenza virus |
19 |
base sequence |
18 |
evolution, molecular |
18 |
swine |
18 |
universal vaccine |
18 |
china - epidemiology |
17 |
virus evolution |
17 |
adult |
16 |
cercopithecus aethiops |
16 |
disease outbreaks |
16 |
influenza a |
16 |
respiratory system - virology |
16 |
sars coronavirus |
16 |
sequence analysis, dna |
16 |
genotype |
15 |
mers-cov |
15 |
rna, viral - genetics |
15 |
sars |
15 |
birds - virology |
14 |
disease outbreaks - statistics & numerical data |
14 |
poultry - virology |
14 |
sars virus - metabolism - pathogenicity |
14 |
swine - virology |
14 |
aged |
13 |
conjunctiva - virology |
13 |
coronavirus - classification - genetics - isolation & purification |
13 |
female |
13 |
genetic variation |
13 |
male |
13 |
molecular epidemiology |
13 |
viral proteins - genetics |
13 |
amino acid sequence |
12 |
astroviridae infections - epidemiology - veterinary - virology |
12 |
bronchi - cytology |
12 |
evolution |
12 |
influenza a virus, h1n1 subtype - metabolism |
12 |
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
12 |
influenza, human - epidemiology - virology |
12 |
influenza, human - virology |
12 |
pandemics |
12 |
proteasome endopeptidase complex - metabolism |
12 |
species specificity |
12 |
t cells |
12 |
time factors |
12 |
transmission |
12 |
virus replication |
12 |
zoonosis |
12 |
adolescent |
11 |
africa |
11 |
antibodies, viral - blood |
11 |
avian influenza |
11 |
cell adhesion molecules - genetics - metabolism |
11 |
chiroptera - virology |
11 |
cho cells - virology |
11 |
cohort studies |
11 |
coronaviruses |
11 |
cricetinae |
11 |
cricetulus |
11 |
feces - virology |
11 |
ferrets - virology |
11 |
genetic predisposition to disease |
11 |
h7n9 |
11 |
homozygote |
11 |
intestine, small - physiology |
11 |
lectins, c-type - genetics - metabolism |
11 |
lung - physiology - virology |
11 |
polymerase chain reaction - methods |
11 |
receptors, cell surface - genetics - metabolism |
11 |
sars virus - genetics |
11 |
severe acute respiratory syndrome - epidemiology - genetics |
11 |
species index: animalia |
11 |
surveillance |
11 |
tandem repeat sequences |
11 |
vero cells - virology |
11 |
avian |
10 |
birds |
10 |
chemicals and cas registry numbers |
10 |
cyclooxygenase 2 - biosynthesis - genetics |
10 |
cyclooxygenase 2 inhibitors |
10 |
genes, viral |
10 |
hemagglutinin glycoproteins, influenza virus - genetics |
10 |
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
influenza a virus, h5n1 subtype - metabolism |
10 |
influenza in birds - enzymology - immunology - virology |
10 |
influenza, human - enzymology - virology |
10 |
influenza, human - metabolism - transmission |
10 |
ip-10 |
10 |
mers |
10 |
neuraminidase - genetics |
10 |
organ culture techniques |
10 |
orthomyxoviridae infections - epidemiology - transmission - veterinary - virology |
10 |
polymerase chain reaction |
10 |
population surveillance |
10 |
prevalence |
10 |
reassortant viruses - isolation & purification |
10 |
receptors, cell surface - metabolism |
10 |
respiratory mucosa - virology |
10 |
sars virus - genetics - isolation & purification |
10 |
viral tropism |
10 |
virulence |
10 |
virus attachment |
10 |
cells, cultured |
9 |
chiroptera - classification - virology |
9 |
coronavirus - classification - genetics |
9 |
h1n1 |
9 |
human |
9 |
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification |
9 |
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification - physiology |
9 |
influenza a virus, h3n2 subtype - classification - genetics - isolation & purification |
9 |
kinetics |
9 |
mamastrovirus - classification - genetics - isolation & purification |
9 |
middle aged |
9 |
molecular sequence numbers |
9 |
pneumonia, viral - virology |
9 |
reverse transcriptase polymerase chain reaction - methods |
9 |
rna interference |
9 |
rna, viral - analysis - genetics |
9 |
rt-qpcr |
9 |
sars virus - isolation & purification |
9 |
serology |
9 |
swine - blood - virology |
9 |
swine diseases - blood - epidemiology - transmission - virology |
9 |
wastewater surveillance |
9 |
adaptation, biological |
8 |
animals, wild - virology |
8 |
antibody-dependent cellular cytotoxicity |
8 |
baseline immunity |
8 |
betacoronavirus |
8 |
bronchi - immunology - pathology |
8 |
canada - epidemiology |
8 |
characterization |
8 |
chemokines |
8 |
cluster analysis |
8 |
coronavirus infection |
8 |
coronavirus infections |
8 |
coronavirus infections - veterinary - virology |
8 |
cytokines - immunology |
8 |
databases, nucleic acid - statistics & numerical data |
8 |
disease progression |
8 |
epidemiology |
8 |
ha stem antibodies |
8 |
heterosubtypic immunity |
8 |
immunity |
8 |
influenza a virus - genetics |
8 |
influenza a virus, h5n1 subtype - immunology |
8 |
influenza virus infection |
8 |
middle east respiratory syndrome coronavirus |
8 |
nucleic acid amplification techniques - methods |
8 |
pandemic h1n1 |
8 |
pathogenesis |
8 |
pathogenicity |
8 |
phenotype |
8 |
positive selection |
8 |
pulmonary alveoli - immunology |
8 |
reassortant viruses - classification - genetics - isolation & purification |
8 |
respiratory mucosa - immunology - pathology |
8 |
sars virus - genetics - immunology |
8 |
sensitivity and specificity |
8 |
sequence homology |
8 |
severe acute respiratory syndrome - epidemiology - transmission - virology |
8 |
singapore - epidemiology |
8 |
universal immune correlate |
8 |
vietnam - epidemiology |
8 |
viral proteins - chemistry - genetics |
8 |
5′-race assay |
7 |
amplicon |
7 |
antibodies |
7 |
antibody |
7 |
antigens, viral - analysis |
7 |
astroviridae - classification - genetics - isolation and purification |
7 |
bayes theorem |
7 |
blood |
7 |
bronchial tissue |
7 |
cell-mediated immunity |
7 |
consensus sequence |
7 |
coronavirus - classification - enzymology - genetics - isolation & purification |
7 |
disease outbreaks - history |
7 |
disease reservoirs |
7 |
dna primers |
7 |
early warnings |
7 |
etiology |
7 |
felidae - virology |
7 |
fractional factorial design |
7 |
genomic sequence |
7 |
hemagglutinin glycoproteins, influenza virus - metabolism |
7 |
history, 20th century |
7 |
history, 21st century |
7 |
influenza a virus - classification - genetics |
7 |
influenza a virus - classification - genetics - isolation & purification |
7 |
influenza a virus, h1n1 subtype - enzymology - genetics - physiology |
7 |
influenza in birds - epidemiology - virology |
7 |
influenza in birds - transmission - virology |
7 |
influenza, human - epidemiology - history |
7 |
influenza, human - epidemiology - transmission - virology |
7 |
influenza, human - transmission - virology |
7 |
models, genetic |
7 |
molecular clock |
7 |
mustelidae - virology |
7 |
nasal tissue |
7 |
nasopharynx - virology |
7 |
nasopharynx/virology |
7 |
neuraminidase - metabolism |
7 |
neutralization tests |
7 |
nucleocapsid proteins - genetics |
7 |
omicron ba.2 |
7 |
orthomyxoviridae infections - epidemiology - transmission - virology |
7 |
public health |
7 |
reassortant |
7 |
rna helicases - genetics |
7 |
rna replicase - genetics |
7 |
rna, viral - analysis |
7 |
rodent diseases - virology |
7 |
rt-pcr |
7 |
sars cov |
7 |
sars virus - isolation and purification |
7 |
saudi arabia |
7 |
serotyping |
7 |
severe acute respiratory syndrome |
7 |
severe acute respiratory syndrome - blood - physiopathology - urine - virology |
7 |
severe acute respiratory syndrome - diagnosis - epidemiology - virology |
7 |
severe acute respiratory syndrome - epidemiology - history - virology |
7 |
severe acute respiratory syndrome - virology |
7 |
sewage surveillance |
7 |
sewage system characteristics |
7 |
subgenomic transcripts |
7 |
vaccination |
7 |
viral genes |
7 |
viral load |
7 |
virology - methods |
7 |
2019 novel coronavirus disease |
6 |
abattoirs |
6 |
administration, oral |
6 |
aerosols |
6 |
air travel-related outbreak |
6 |
alveolar epithelial cells |
6 |
amoxicillin-potassium clavulanate combination - administration & dosage |
6 |
antibodies, monoclonal - diagnostic use |
6 |
biodiversity |
6 |
biodiversity conservation |
6 |
biopsy |
6 |
blotting, western |
6 |
bronchi - pathology |
6 |
camel |
6 |
carnivora - virology |
6 |
cell nucleus - ultrastructure |
6 |
child, preschool |
6 |
clade 2.3.4.4.b |
6 |
conservation of natural resources |
6 |
coronavirus - classification - genetics - immunology - isolation & purification |
6 |
coronavirus - classification - isolation & purification - ultrastructure |
6 |
coronavirus 229e, human - immunology |
6 |
coronavirus disease |
6 |
coronavirus infections - diagnosis - transmission - virology |
6 |
coronavirus oc43, human - immunology |
6 |
cross infection - complications |
6 |
cross-reactive antibody response |
6 |
cytokine |
6 |
cytokines - biosynthesis - genetics |
6 |
cytokines - genetics - metabolism |
6 |
cytopathogenic effect, viral |
6 |
disease transmission control |
6 |
dna helicases - classification - genetics - metabolism |
6 |
dna, viral - classification - genetics |
6 |
dna, viral - genetics |
6 |
dna, viral - genetics - metabolism |
6 |
ducks - virology |
6 |
early diagnosis |
6 |
family characteristics |
6 |
far east - epidemiology |
6 |
fatal outcome |
6 |
follow-up studies |
6 |
gene expression regulation |
6 |
genes, viral - genetics |
6 |
genomic diversity |
6 |
genomic epidemiology |
6 |
giant cells - ultrastructure |
6 |
h5n1 |
6 |
hiv protease inhibitors - therapeutic use |
6 |
hospitalization |
6 |
hpai |
6 |
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification - pathogenicity |
6 |
influenza a virus, h1n1 subtype - genetics - pathogenicity |
6 |
influenza a virus, h1n2 subtype - classification - genetics - isolation & purification |
6 |
influenza a virus, h3n2 subtype - genetics - pathogenicity |
6 |
influenza a virus, h5n1 subtype - classification - genetics |
6 |
influenza a(h1n1)pdm09 |
6 |
influenza a(h5n1) |
6 |
influenza in birds - diagnosis - genetics - virology |
6 |
influenza polymerase |
6 |
influenza, human - diagnosis - genetics - virology |
6 |
influenza, human - immunology - virology |
6 |
influenza, human - transmission |
6 |
influenzavirus a - genetics - immunology - pathogenicity |
6 |
infusions, intravenous |
6 |
length of stay |
6 |
lung - pathology - virology |
6 |
lung - radiography |
6 |
macrophages - immunology |
6 |
macrophages - immunology - virology |
6 |
membrane glycoproteins - chemistry - genetics |
6 |
metaplasia |
6 |
microscopy, electron |
6 |
molecular diagnostic techniques - methods |
6 |
mutation - genetics |
6 |
nasal cavity - virology |
6 |
neuraminidase inhibition antibody |
6 |
neutralization |
6 |
nose - virology |
6 |
nsp6 |
6 |
nucleocapsid proteins - analysis |
6 |
nucleoside-triphosphatase - classification - genetics - metabolism |
6 |
ofloxacin |
6 |
open reading frames - genetics |
6 |
opportunistic infections - diagnosis - transmission - virology |
6 |
organ size |
6 |
orthomyxoviridae - genetics - isolation & purification - pathogenicity |
6 |
orthomyxoviridae infections - transmission |
6 |
orthomyxoviridae infections - transmission - veterinary - virology |
6 |
owston's civet |
6 |
pandemic risk assessment |
6 |
pharynx - virology |
6 |
polymorphism, genetic |
6 |
pregnancy |
6 |
pregnancy complications, infectious - diagnosis - therapy |
6 |
prospective studies |
6 |
pulse therapy, drug |
6 |
pyrimidinones - therapeutic use |
6 |
quantitative rt-pcr |
6 |
real time rt-pcr |
6 |
reassortant viruses - genetics - isolation & purification - pathogenicity |
6 |
regional index: china |
6 |
residence characteristics |
6 |
respiratory infections |
6 |
respiratory tract infections |
6 |
reverse transcriptase polymerase chain reaction - methods - standards |
6 |
risk assessment |
6 |
risk factors |
6 |
ritonavir - therapeutic use |
6 |
rna helicases - classification - genetics - metabolism |
6 |
rna, messenger - analysis |
6 |
rna, viral |
6 |
rna, viral - analysis - isolation & purification |
6 |
rna, viral - genetics - isolation & purification |
6 |
sars coronavirus 2 |
6 |
sars virus - classification - genetics - immunology - isolation & purification |
6 |
sars virus - enzymology - genetics |
6 |
sars virus - genetics - immunology - isolation & purification |
6 |
sars virus - immunology |
6 |
sars virus - pathogenicity |
6 |
sars virus - physiology |
6 |
seasons |
6 |
sequence deletion |
6 |
sequence homology, amino acid |
6 |
sequence homology, nucleic acid |
6 |
sequence variation |
6 |
seroepidemiology |
6 |
severe acute respiratory syndrome - blood - immunology |
6 |
severe acute respiratory syndrome - complications - pathology - virology |
6 |
severe acute respiratory syndrome - diagnosis - drug therapy - epidemiology - virology |
6 |
severe acute respiratory syndrome - diagnosis - immunology - virology |
6 |
severe acute respiratory syndrome - diagnosis - transmission - virology |
6 |
severe acute respiratory syndrome - diagnosis - virology |
6 |
severe acute respiratory syndrome - drug therapy - virology |
6 |
severe acute respiratory syndrome - epidemiology - microbiology |
6 |
severe acute respiratory syndrome - immunology - virology |
6 |
severe acute respiratory syndrome - mortality - physiopathology - virology |
6 |
severity of illness index |
6 |
specimen handling |
6 |
substrate specificity |
6 |
survival rate |
6 |
swine diseases - epidemiology - transmission - virology |
6 |
tumor necrosis factor-alpha - biosynthesis - genetics |
6 |
variant |
6 |
vero cells |
6 |
viral envelope proteins - chemistry - genetics |
6 |
viral load - statistics & numerical data |
6 |
viral proteins - genetics - metabolism |
6 |
virus cultivation |
6 |
viruses |
6 |
viverrid |
6 |
viverridae - anatomy & histology - physiology - virology |
6 |
wastewater genome sequencing |
6 |
wastewater-based epidemiology |
6 |
whole genome sequencing |
6 |
wild species infections |
6 |
actins - genetics |
5 |
adaptation |
5 |
adcc |
5 |
adjuvant |
5 |
amino acid substitution |
5 |
b cell |
5 |
betacoronaviruses |
5 |
calibration |
5 |
cell line |
5 |
chicken meat |
5 |
communicable diseases, emerging |
5 |
comorbidity |
5 |
consensus primers |
5 |
coronavirus - classification - isolation and purification |
5 |
coronavirus - genetics - isolation & purification |
5 |
cytokines - metabolism |
5 |
deubiquitylases |
5 |
diagnostics |
5 |
diarrhea |
5 |
dna, complementary - analysis |
5 |
dna, protozoan - blood - genetics |
5 |
dna, ribosomal - analysis |
5 |
dna, viral - analysis - genetics |
5 |
dna, viral - chemistry - genetics |
5 |
dromedary camels |
5 |
feces analysis |
5 |
fomite |
5 |
gyrovirus |
5 |
ha stem |
5 |
haplorhini |
5 |
hemagglutinin glycoproteins, influenza virus - classification - genetics |
5 |
hot temperature |
5 |
immunohistochemistry |
5 |
indirubin |
5 |
infection |
5 |
influenza a virus |
5 |
influenza a virus - classification - enzymology - genetics |
5 |
influenza a virus - enzymology - genetics |
5 |
influenza a virus - genetics - isolation & purification |
5 |
influenza a virus, h1n1 subtype - classification - genetics - isolation and purification |
5 |
influenza a virus, h2n2 subtype - classification - genetics - isolation & purification |
5 |
influenza a virus, h3n2 subtype - classification - genetics - isolation and purification |
5 |
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
5 |
influenza in birds - enzymology |
5 |
influenza in birds - epidemiology - genetics |
5 |
influenza, human - diagnosis - virology |
5 |
innate immune response |
5 |
interferon type i - pharmacology |
5 |
interferon-gamma - pharmacology |
5 |
macrophages |
5 |
malaria, falciparum - blood - diagnosis |
5 |
mammals - virology |
5 |
membrane glycoproteins - genetics |
5 |
methods |
5 |
molecular diagnostic techniques - economics - methods |
5 |
mpox virus |
5 |
mutation |
5 |
mutations |
5 |
norovirus |
5 |
nucleoprotein |
5 |
omicron |
5 |
omicron variants |
5 |
open reading frames |
5 |
orthomyxoviridae infections - diagnosis - virology |
5 |
orthomyxoviridae infections - epidemiology - veterinary - virology |
5 |
plasmodium falciparum - genetics - isolation & purification |
5 |
pneumocytes |
5 |
polymerase |
5 |
polymerase chain reaction - economics - methods - standards |
5 |
polymerase genes |
5 |
rapid diagnosis |
5 |
reagent kits, diagnostic |
5 |
real-time pcr |
5 |
reassortant viruses - classification - genetics - isolation and purification |
5 |
reference standards |
5 |
reverse transcriptase polymerase chain reaction - economics - methods |
5 |
rig-i signaling |
5 |
rna replicase - chemistry - genetics |
5 |
rna virus |
5 |
rna, ribosomal, 18s - genetics |
5 |
rna, viral - analysis - genetics - isolation & purification |
5 |
rna, viral - biosynthesis |
5 |
rotavirus |
5 |
sars virus - genetics - growth & development - isolation & purification |
5 |
selection |
5 |
sequencing |
5 |
serial passage |
5 |
severe acute respiratory syndrome - blood - mortality - virology |
5 |
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control - transmission - virology |
5 |
specimen handling - methods |
5 |
swine diseases - epidemiology - virology |
5 |
syrian hamsters |
5 |
ubiquitylation |
5 |
viral envelope proteins - genetics |
5 |
viral matrix proteins - genetics |
5 |
virus dna |
5 |
virus replication - drug effects |
5 |
2019 ncov whu01 |
4 |
adjuvants, immunologic - administration and dosage |
4 |
algorithm |
4 |
animal experiment |
4 |
animal model |
4 |
animal tissue |
4 |
antibody dependent enhancement |
4 |
antigen binding |
4 |
antigen detection |
4 |
antigens, viral - analysis - immunology |
4 |
betacov/nepal/61/2020 |
4 |
bioinformatics |
4 |
chemistry |
4 |
clinical trials |
4 |
coating |
4 |
codon usage analysis |
4 |
cohort |
4 |
communicable diseases, emerging - epidemiology - virology |
4 |
coronavirus infections - diagnosis - mortality |
4 |
cross‐neutralization |
4 |
digital rt-pcr |
4 |
disease association |
4 |
disease surveillance |
4 |
dromedary |
4 |
dromedary camel |
4 |
elisa |
4 |
equine coronavirus |
4 |
ethiopia |
4 |
genetics |
4 |
hajj |
4 |
hemagglutinin-stalk |
4 |
hku23 |
4 |
il-15 |
4 |
immunity, duration |
4 |
immunoassay - methods |
4 |
immunology |
4 |
influenza a virus - classification - genetics - growth & development - isolation & |
4 |
influenza a virus - classification - genetics - pathogenicity |
4 |
influenza a virus, h1n1 subtype - genetics |
4 |
influenza a virus, h1n1 subtype - immunology - isolation and purification |
4 |
influenza a virus, h5n1 subtype - classification - immunology |
4 |
influenza a virus, h5n1 subtype - genetics - pathogenicity |
4 |
influenza a virus, h9n2 subtype |
4 |
influenza virus vaccines |
4 |
influenza, human - diagnosis - mortality |
4 |
interleukin-15 - administration and dosage - immunology |
4 |
introns |
4 |
live vector vaccines |
4 |
macrophages - virology |
4 |
molecular diagnosis |
4 |
molecular typing |
4 |
mouse-adaptation |
4 |
neutralizing antibody |
4 |
next-generation sequencing |
4 |
nk cells |
4 |
orthomyxoviridae infections - immunology - prevention and control |
4 |
orthomyxoviridae infections - virology |
4 |
pandemic |
4 |
pb2 |
4 |
pb2-627 |
4 |
ph-responsive peptide |
4 |
point mutation |
4 |
point-of care |
4 |
protection |
4 |
pulmonary delivery |
4 |
random mutagenesis |
4 |
real time-pcr |
4 |
reassortant viruses - genetics |
4 |
reassortant viruses - immunology - isolation and purification |
4 |
reproducibility of results |
4 |
respiratory syncytial virus infections - diagnosis - mortality |
4 |
rna, viral - genetics - isolation and purification |
4 |
severe acute respiratory syndrome - diagnosis |
4 |
small interfering rna |
4 |
spray drying |
4 |
t cell |
4 |
tumor necrosis factor-alpha - metabolism |
4 |
universal vaccines |
4 |
vaccinia |
4 |
vaccinia virus - genetics - immunology |
4 |
viral nonstructural proteins - genetics |
4 |
wca |
4 |
abattoir |
3 |
age factors |
3 |
air travel |
3 |
aircraft |
3 |
antibodies, monoclonal - administration and dosage - genetics - immunology - therapeutic use |
3 |
antibodies, monoclonal - chemistry - immunology - isolation and purification |
3 |
antigens, viral - immunology |
3 |
antiviral agents - pharmacology - therapeutic use |
3 |
astro viruses |
3 |
b-lymphocytes - immunology - virology |
3 |
bird diseases - physiopathology - transmission - virology |
3 |
chimera |
3 |
co-infection |
3 |
communicable diseases, emerging - mortality - transmission - virology |
3 |
coronavirus disease 2019 |
3 |
droplet microfluidics |
3 |
emerging pathogens |
3 |
eyfp, gene encoding the enhanced yellow fluorescent protein |
3 |
genetic variability |
3 |
human respiratory viruses |
3 |
immunization, passive |
3 |
immunoglobulin m - immunology |
3 |
immunologic memory - immunology |
3 |
influenza a virus - classification - isolation & purification - pathogenicity |
3 |
influenza a virus, h1n1 subtype - genetics - isolation and purification - pathogenicity |
3 |
influenza a virus, h1n1 subtype - immunology |
3 |
influenza a virus, h5n1 subtype |
3 |
influenza a virus, h5n1 subtype - genetics - isolation & purification |
3 |
influenza b virus |
3 |
influenza vaccines |
3 |
influenza, human - drug therapy - epidemiology - prevention & control - transmission |
3 |
influenza, human - epidemiology - therapy |
3 |
lineage differentiation |
3 |
livestock - virology |
3 |
mdck, madin-darby canine kidney |
3 |
membrane glycoproteins - genetics - immunology - physiology |
3 |
middle east respiratory syndrome |
3 |
novel |
3 |
ns1, gene encoding the non-structural protein ns1 |
3 |
orthomyxoviridae - drug effects - immunology - pathogenicity |
3 |
orthomyxoviridae - genetics - isolation and purification - pathogenicity |
3 |
oseltamivir - therapeutic use |
3 |
pandemic h1n1 2009 |
3 |
pandemic influenza |
3 |
pandemics - prevention and control |
3 |
ptgs, post-transcriptional gene silencing |
3 |
quantitative collection |
3 |
rapid antigen detection kit |
3 |
real time quantitative rt-pcr |
3 |
reassortant virus |
3 |
reassortant viruses - genetics - isolation and purification - pathogenicity |
3 |
respiration, artificial |
3 |
rnai, rna interference |
3 |
rt-ddpcr |
3 |
sars virus |
3 |
sars virus - classification - genetics |
3 |
seasonal h1n1 and h3n2 |
3 |
single cell |
3 |
sirna, small-interfering rna |
3 |
south-east asia |
3 |
swine influenza |
3 |
victoria |
3 |
vietnam |
3 |
yamagata |
3 |
2009 h1n1 influenzaanti |
2 |
8b protein |
2 |
accessory proteins |
2 |
accidental deaths |
2 |
antibiotic therapy |
2 |
antibodies, monoclonal - chemistry - immunology |
2 |
antibodies, monoclonal - immunology - isolation and purification |
2 |
antibodies, neutralizing - chemistry - immunology |
2 |
antibodies, neutralizing - immunology - isolation and purification |
2 |
antibodies, viral - immunology - isolation and purification |
2 |
antibody detection |
2 |
antibody production |
2 |
antibody vaccine |
2 |
antigens, viral - chemistry - genetics - immunology |
2 |
arterial oxygen tension |
2 |
artificial ventilation |
2 |
bacterium culture |
2 |
bat coronaviruses |
2 |
betacorona |
2 |
biology |
2 |
body response |
2 |
broad-spectrum vaccine |
2 |
case report |
2 |
clinical article |
2 |
clinical diagnosis |
2 |
clinical outcome |
2 |
codon |
2 |
codon usage |
2 |
conserved sequence |
2 |
contamination |
2 |
controlled study |
2 |
coronavirinae |
2 |
coronavirus - genetics |
2 |
cu2o |
2 |
cuo cupric oxide |
2 |
cuprous oxide |
2 |
diagnosis |
2 |
dinucleotide usage |
2 |
disease severity |
2 |
disease x |
2 |
disinfection |
2 |
drowning |
2 |
ecology |
2 |
emerging infectious diseases |
2 |
envelope (e) |
2 |
escherichia coli |
2 |
filtration |
2 |
flongle |
2 |
genome organization |
2 |
hemagglutinin glycoproteins, influenza virus - chemistry - genetics - immunology |
2 |
hemagglutinin glycoproteins, influenza virus - immunology |
2 |
immunodominant epitopes - chemistry - immunology |
2 |
influenza b virus - immunology |
2 |
influenza vaccines - immunology |
2 |
messenger |
2 |
mice |
2 |
microbiology |
2 |
minion |
2 |
missense mutation |
2 |
molecular detection |
2 |
nanopore |
2 |
nidovirus |
2 |
novel coronaviruses |
2 |
orthomyxoviridae infections - prevention & control |
2 |
passive immunization |
2 |
peptide-mapping |
2 |
picobirnavirus - classification - genetics - isolation and purification - pathogenicity |
2 |
proteasome pathway |
2 |
protein conformation |
2 |
rdrp |
2 |
reassortment |
2 |
replicase |
2 |
respiratory system |
2 |
respiratory tract infections - epidemiology - transmission - veterinary - virology |
2 |
ring vaccination |
2 |
rna |
2 |
rna processing |
2 |
rna virus infections - epidemiology - transmission - veterinary - virology |
2 |
sars virus - genetics - isolation and purification |
2 |
sars virus - genetics - metabolism - physiology |
2 |
severe acute respiratory syndrome coronavirus (sars-cov) |
2 |
subgenomic mrna synthesis |
2 |
sus scrofa - virology |
2 |
swimming pools |
2 |
ubiquitin-independent |
2 |
viral diagnosis |
2 |
viral envelope proteins - metabolism |
2 |
viral proteins - metabolism |
2 |
viricidal |
2 |
virus |
2 |
virus culture |
2 |
virus replication - genetics |
2 |
acidic polymerase protein (pa) avian influenza |
1 |
adenosine triphosphate - metabolism |
1 |
antiviral agent |
1 |
apoptosis |
1 |
apoptosis - drug effects |
1 |
bacterial typing techniques |
1 |
basic polymerase protein 1 (pb1) basic polymerase protein 2 (pb2) genomic rnas |
1 |
biological markers |
1 |
biological transport |
1 |
blood specimen collection - methods |
1 |
cd8 t cell |
1 |
cell death - drug effects |
1 |
cell differentiation |
1 |
cell line - virology |
1 |
cell nucleus - metabolism |
1 |
cell-free |
1 |
chick embryo |
1 |
cloning, molecular |
1 |
coinfection |
1 |
coronavirus 229e, human - classification - genetics - isolation & purification |
1 |
coronavirus oc43, human - classification - genetics - isolation & purification |
1 |
cross-reactive antibody |
1 |
cytotoxicity |
1 |
dna - blood |
1 |
dna - blood - genetics |
1 |
dna - blood - isolation & purification |
1 |
dna methylation |
1 |
dna-binding proteins - genetics - metabolism |
1 |
dna-directed rna polymerases - metabolism |
1 |
dogs |
1 |
dose-response relationship, drug |
1 |
down syndrome - diagnosis |
1 |
down syndrome - diagnosis - embryology |
1 |
down-regulation |
1 |
embryo, mammalian - drug effects |
1 |
emerging infectious disease |
1 |
endonucleases - metabolism |
1 |
entropy |
1 |
eye proteins |
1 |
feasibility studies |
1 |
fetal blood - chemistry |
1 |
fetal blood - chemistry - metabolism |
1 |
fetal cell |
1 |
fetal diseases - diagnosis |
1 |
fetal dna |
1 |
fetal rna |
1 |
fetus - metabolism |
1 |
gene expression regulation, viral - drug effects |
1 |
genomic imprinting |
1 |
glycosylation |
1 |
hela cells |
1 |
hemagglutinin |
1 |
heterozygote |
1 |
homeodomain proteins |
1 |
in situ hybridization, fluorescence |
1 |
influenza a virus - drug effects - enzymology - genetics - physiology |
1 |
influenza a virus - enzymology |
1 |
influenza a virus - genetics - metabolism |
1 |
influenza a virus, h1n1 subtype - genetics - physiology |
1 |
influenza a virus, h3n2 subtype - genetics - physiology |
1 |
influenza a virus, h7n7 subtype - genetics - physiology |
1 |
influenza, human - genetics |
1 |
intercalating agents - pharmacology |
1 |
kidney |
1 |
maternal plasma |
1 |
maternal-fetal exchange |
1 |
mesoderm - drug effects - metabolism |
1 |
mice, inbred icr |
1 |
models, biological |
1 |
mouse embryo |
1 |
mutagenesis |
1 |
nervous system - drug effects - embryology - metabolism |
1 |
nervous system malformations - chemically induced - embryology |
1 |
neural tissue |
1 |
neurons |
1 |
neutralization assay |
1 |
noninvasive |
1 |
nucleic acid conformation |
1 |
oligonucleotide array sequence analysis - methods |
1 |
orthomyxoviridae |
1 |
orthomyxoviridae - genetics |
1 |
paired box transcription factors |
1 |
phosphorus radioisotopes |
1 |
plasma dna |
1 |
plasmids - metabolism |
1 |
plasmodium |
1 |
poly a - metabolism |
1 |
poly u - metabolism |
1 |
polymorphism, single nucleotide |
1 |
pregnancy - blood |
1 |
prenatal diagnosis |
1 |
prenatal diagnosis - methods |
1 |
promoter regions, genetic |
1 |
proteins - drug effects - metabolism |
1 |
pseudovirus |
1 |
recombination, genetic |
1 |
recombination, genetic - genetics |
1 |
repressor proteins |
1 |
retinoic acid |
1 |
rna - blood |
1 |
rna polymerase ii - metabolism |
1 |
rna replicase - metabolism |
1 |
rna, complementary - chemistry |
1 |
rna, messenger - biosynthesis |
1 |
rna, messenger - biosynthesis - chemistry - metabolism |
1 |
rna, messenger - biosynthesis - genetics |
1 |
rna, messenger - blood |
1 |
rna, messenger - chemistry - metabolism |
1 |
rna, messenger - genetics - metabolism |
1 |
rna, messenger - metabolism |
1 |
rna, viral - biosynthesis - genetics |
1 |
rna, viral - chemistry |
1 |
rna, viral - chemistry - metabolism |
1 |
rna, viral - physiology - ultrastructure |
1 |
s-protein |
1 |
sars virus - classification - genetics - isolation & purification |
1 |
single-strand specific dna and rna endonucleases - metabolism |
1 |
structure-activity relationship |
1 |
systems biology |
1 |
tail - cytology - drug effects - embryology |
1 |
tail bud |
1 |
templates, genetic |
1 |
transcription factors |
1 |
transcription, genetic |
1 |
transcription, genetic - drug effects |
1 |
transfection |
1 |
tretinoin - metabolism - pharmacology |
1 |
viral evolution |
1 |
viral rna |
1 |
virion - genetics |
1 |
virology |
1 |
vrna |
1 |
wnt proteins |
1 |
wnt-3a |
1 |
wnt3 protein |
1 |
wnt3a protein |
1 |
y chromosome |
1 |
zinc fingers |
1 |